

Author: Zhang HF Zhao KJ Yang PF Fang YB Zhang YH Liu JM Huang QH
Publisher: Field House Publishing
ISSN: 0300-0605
Source: The Journal of International Medical Research, Vol.40, Iss.5, 2012-09, pp. : 1708-1714
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Is Fibroblast Growth Factor Receptor 4 a Suitable Target of Cancer Therapy?
Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. :


Fibroblast Growth Factor Receptor Inhibitors
Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. :



